Skip to main content
Euroasian Journal of Hepato-Gastroenterology logoLink to Euroasian Journal of Hepato-Gastroenterology
. 2017 Sep 29;7(2):117–121. doi: 10.5005/jp-journals-10018-1230

Psychological Results of 438 Patients with persisting Gastroesophageal Reflux Disease Symptoms by Symptom Checklist 90-Revised Questionnaire

Xia Chen 1,, Ping Li 1, Fei Wang 1, Guozhong Ji 1, Lin Miao 1, Sihong You 1
PMCID: PMC5670252  PMID: 29201791

Abstract

Aims and objectives:

Gastroesophageal reflux disease (GERD) affects mental state and social activities. On the contrary, mental disorders may also play a crucial role in GERD symptoms. The purpose of the study was to analyze the data of Symptom Checklist 90-Revised (SCL-90-R) questionnaire from patients with persisting GERD and to explore the impact of psychological factors on them.

Materials and methods:

The patients accepted SCL-90-R questionnaire survey, following endoscopy, high-resolution manometry (HRM), and ambulatory impedance-pH monitoring. Based on these results, we divided patients into different groups. The result of SCL-90-R was also compared with degree of acid reflux, symptoms, symptom duration, and gender.

Results:

The data from 438 patients were analyzed. All patients were divided into reflux esophagitis (RE; 63, 14.38%); nonerosive gastroesophageal reflux disease (NERD; 106, 24.20%); functional heartburn (FH; 123, 28.08%), hypersensitive esophagus (HE; 67, 15.29%), diffuse esophageal spasm (DES; 5: 1.14%), hypertensive (10, 3.42%); weak peristalsis (14, 3.20%); achalasia (50, 11.42%). There were significant differences between different groups regarding depression (DEP), anxiety (ANX), paranoid ideation (PAR), and psychoticism (PSY). The patients with ≥2 years with GERD presented with increased scores in DEP, ANX, and PSY. Women had dramatically higher scores than men in each domain (p < 0.05).

Conclusion:

Data have shown that GERD patients exhibit differential levels of psychological symptoms. Long duration of GERD was related to typical plus atypical symptoms and females seem to be more prone to develop psychological disorders.

How to cite this article: Chen X, Li P, Wang F, Ji G, Miao L, You S. Psychological Results of 438 Patients with persisting Gastroesophageal Reflux Disease Symptoms by Symptom Checklist 90-Revised Questionnaire. Euroasian J Hepato-Gastroenterol 2017;7(2):117-121.

Keywords: Gastroesophageal reflux disease, High-resolution manometry, Impedance-pH monitoring, Refractory proton pump inhibitor symptoms, Symptom checklist 90-Revised questionnaire.

INTRODUCTION

Due to several factors, the incidence of GERD has been increasing in Asian and Western countries.1,2 Therapeutic strategy for GERD mainly involves the use of proton pump inhibitors (PPIs). Despite treatment with standard PPI dose, unfortunately, 20 to 30% of patients still suffer from troublesome GERD symptoms.3 Persisting GERD symptoms cause discomfort, impair quality of life, and affect mental state and social activities. Likewise, the subsequent development of mental disorders, such as ANX, and depressive symptoms also plays a crucial role on GERD symptom deterioration and has a negative effect on people’s quality of life.4

As a self-report questionnaire may be able to provide multidimensional and normative data, the SCL-90-R is widely used for all psychiatric patients. Some medical groups applied SCL-90-R to evaluate the psychological state of patients with chronic diseases.5,6 Previous studies suggest that the SCL-90-R could be valuable in evaluating psychological factors and, therefore, recommend it for psychosocial investigation in varied disease clinical practice.7-9 However, data from patients with persisting refractory GERD symptom based on SCL-90-R questionnaire have not been properly evaluated.

This study focused on the psychological state of refractory GERD patients using SCL-90-R. We intended to find the differences between several conditions of refractory GERD symptom and to assess if SCL-90-R would be a new, simple method for screening patients with GERD in a community hospital. Consequently, it may be helpful for gastroenterologists to choose relatively precise diagnostic approaches.

MATERIALS AND METHODS

The target patients were all with persisting GERD symptoms after 8-week trial of once-daily PPI therapy from October 2010 to November 2015.

Exclusion criteria included previous psychopathological disease; previous digestive disease surgery; organic disease in digestive tract; severe comorbidity; any type of cancer; currently taking psychological drugs; and diagnosis of functional gastrointestinal disorders (FGIDs).

The tests, such as SCL-90-R,10 upper gastrointestinal endoscopy, and HRM (Given Imaging, Los Angeles, California) were accomplished; 24-hour impedance-pH monitoring (Given Imaging, Los Angeles, California) was done. Data of HRM and impedance-pH monitoring analysis were performed using software (Mano View software; Sierra Scientific Instrument Inc, Los Angeles, California).

The SCL-90-R consists of 90 items, evaluating psychopathological and somatic status on a 4-point scale. The scale ranges from 0 (absence of the symptom) to 4 (maximum disturbance). These items are divided into nine scale markers as: DEP; somatization (SOM); ANX; obsessive-compulsive behavior (O-C); hostility (HOS); interpersonal sensitivity (I-S); phobic anxiety (PHOB); PSY; and PAR. Every dimension includes 6 to 13 questions. The score on each dimension represents the mean score of the dimension and directly reflects the severity of the mental health problem. Subscale scores >2 were suggestive of potential mental health issues. The global severity index (GSI) indicates the mean score of 90 items.11

Based on endoscopy, HRM, and impedance-pH monitoring, we divided patients into subgroups, such as NERD, RE, FH, HE, DES, hypertensive, weak peristalsis, and achalasia. The diagnosis was made and classified according to the Chicago classification and previously published criteria.12,13

STATISTICAL ANALYSIS

Data analysis was performed independently by two investigators unaware of the status of individuals. The data were shown as mean ± standard deviation. Analysis of variance for continuous variables and Pearson’s chi-square test for categorical variables using Statistical Package for the Social Sciences version 13.0 was accomplished. A p-value <0.05 was significant and all p values were two-sided.

RESULTS

Clinical Characteristics

A total of 438 patients (137 male, 301 female, age 51.42 ± 17.30 years) were analyzed in this study (Table 1). Symptom duration of these patients was 4.02 ± 1.45 years. There were 271 (61.87%) patients with heartburn and 239 (54.57%) with regurgitation, 189 (43.15%) with retrosternal discomfort and pain (Table 1). All patients were divided into RE (63, 14.38%), NERD (106, 24.20%), FH (123, 28.08%), HE (67, 15.29%), DES (5, 1.14%), hypertensive (10, 3.42%), weak peristalsis (14, 3.20%), achalasia (50, 11.42%).

Table 1: Demographics and clinical characteristics

Characteristics (n = 438)      n      %     
Age (years)      51.42 ± 17.30          
  Range      19-83          
Gender               
  Male      137      31.28     
  Female      301      68.72     
BMI      23.42 ± 10.37          
RE      63      14.38     
NERD      106      24.20     
HE      123      28.08     
FH      67      15.29     
DES      5      1.14     
Hypertensive      10      3.42     
Weak peristalsis      14      3.20     
Achalasia      49      11.19     
Smoking      142      32.42     
Alcohol consumption      145      33.10     
Drug history               
  Calcium ion antagonist      179      40.87     
  Aspirin      153      34.93     
  Hypnotic drug      51      11.64     
Past medical history      253          
Symptom               
  Duration (years)      4.02±1.45          
  Heartburn      271      61.87     
  Regurgitation      239      54.57     
  Retrosternal discomfort and pain      189      43.15     
  Cough      74      16.89     
  Asthma      19      4.34     
  Hoarseness      34      7.76     
  Throat discomfort      195      44.52     
Foreign body sensation in throat      113      25.80     
Globus sensation      63      14.38     
Belching      204      46.58     
  Dysphagia      152      34.70     
  Epigastric pain and epigastric discomfort      204      46.58     

BMI: Body Mass Index

SCL-90-R Questionnaire Survey

We investigated the scores of SCL-90-R in different groups (Table 2). The results indicated that the scores had significant differences between various groups as shown by DEP, ANX, PAR, PSY, and GSI. In DEP domain, the score in RE group was less than that in NERD, FH, achalasia groups (p < 0.05); the score in NERD was more than in HE and hypertensive groups (p < 0.05); the score in FH was more than in hypertensive and HE (p < 0.05); the score in achalasia was more than in HE as well as hypertensive groups (p < 0.05). About ANX domain, we found RE group had less score than in NERD and achalasia groups (p < 0.05); NERD group had more than HE group (p < 0.05); FH group had more score than HE group (p < 0.05); achalasia had more score than HE and hypertensive groups (p < 0.05). For PSY, the score of achalasia group showed higher level than RE, NERD, FH, and HE groups (p < 0.05); the score of FH group was more than hypertensive group (p < 0.05). For PAR, NERD group had more score than HE, hypertensive and achalasia groups (p < 0.05), and hypertensive group had more score than DES group (p < 0.05). According to the result of GSI domain, the data revealed that the level of NERD was higher than RE, FH, and HE groups (p < 0.05).

Table 2: Scores in different groups

  RE (n = 63)   HE (n = 67)   FH (n = 123)   NERD (n = 106)   Achalasia (n = 50)   Hypertensive (n = 10)   DES (n = 5)   Weak (n = 14)  
SOM   1.39 ± 0.58   1.46 ± 0.62   1.57 ± 0.67   1.40 ± 0.62   1.54 ± 0.66   1.66 ± 0.72   1.20 ± 0.59   1.46 ± 0.90  
O-C   1.50 ± 0.54   1.42 ± 0.64   1.55 ± 0.63   1.50 ± 0.63   1.62 ± 0.73   1.39 ± 0.56   1.94 ± 0.70   1.62 ± 0.73  
I-S   1.43 ± 0.67   1.35 ± 0.66   1.38 ± 0.57   1.40 ± 0.59   1.48 ± 0.71   1.57 ± 0.75   1.20 ± 0.59   1.60 ± 0.69  
DEP*   1.48 ± 0.64   1.51 ± 0.65   1.77 ± 0.59   1.80 ± 0.59   1.76 ± 0.66   1.27 ± 0.54   1.65 ± 0.67   1.61 ± 0.81  
ANX*   1.50 ± 0.60   1.46 ± 0.70   1.69 ± 0.62 1.70 ± 0.53   1.87 ± 0.66   1.34 ± 0.57   1.57 ± 1.06   1.72 ± 0.73  
HOS   1.44 ± 0.56   1.40 ± 0.62   1.40 ± 0.61   1.39 ± 0.67   1.35 ± 0.56   1.40 ± 0.84   1.20 ± 0.59   1.51 ± 0.75  
PHOB   1.48 ± 0.64   1.47 ± 0.62   1.42 ± 0.58   1.47 ± 0.64   1.56 ± 0.68   1.20 ± 0.57   1.57 ± 1.06   1.37 ± 0.56  
PAR*   1.27 ± 0.49   1.16 ± 0.47   1.27 ± 0.47   1.32 ± 0.57   1.12 ± 0.44   0.96 ± 0.36   0.56 ± 0.51   1.36 ± 0.51  
PSY*   1.26 ± 0.47   1.31 ± 0.53   1.23 ± 0.51   1.27 ± 0.50   1.59 ± 0.57   1.58 ± 0.60   1.67 ± 0.48   1.51 ± 0.50  
GSI*   1.04 ± 0.41   1.01 ± 0.42   1.02 ± 0.38   1.18 ± 0.38   1.07 ± 0.44   1.17 ± 0.47   0.94 ± 0.43   1.11 ± 0.44  

*p < 0.05 between groups

The nine domains with DeMeester pathological (>14.72, n = 114) and normal (<14.72, n = 245) values showed no statistical differences (p > 0.05; Graph 1). However, we found statistically significant differences between the patients with less duration of GERD symptoms (<2 years, n = 95) with those with prolonged GERD duration (>2 years, n = 343). The patients with more duration presented more scores in DEP, ANX, and PSY (p <0.05; Graph 2). But the score of PAR was lower in >2 years group (p < 0.05). Subjects with GERD typical plus atypical symptoms (n = 253) had higher scores compared with subjects only with typical symptoms (n = 185) in SOM, ANX, PSY, and GSI (p < 0.05; Graph 3). Compared with gender, women had dramatically higher scores than men in these nine domains (all p < 0.05; Graph 4).

Graph 1:

Graph 1:

SCL-90-R scores based on DeMeester value. No differences were detected in nine domains and GSI between DeMeester value 214.72 and DeMeester value <14.72

Graph 2:

Graph 2:

SCL-90-R scores depending on symptom duration. Significant differences were seen in DEP, ANX, PAR, and PSY domains. *p < 0.05

Graph 3:

Graph 3:

SCL-90-R scores based on symptom. Significant differences were seen in SOM, ANX, and PSY domains and GSI. *p < 0.05

Graph 4:

Graph 4:

SCL-90-R scores based on gender. The scores of females were significantly more than those of males in all domains and GSI. *p < 0.05

DISCUSSION

Psychosocial factors are able to exert influence on deterioration of disease, symptoms, responses to treatment, and the quality of life. Researchers evaluated the psychological status of patients with chronic disease using SCL-90-R questionnaire. A link of GERD and psycho-pathological features has already been demonstrated by several studies.14,15 We analyzed the data from the patients with refractory GERD symptoms in order to acquire their psychological characteristics, which may be helpful for making diagnosis and clinical strategy.

In this study, O-S and I-S, which are stable personality characters and are referred as personality, were not found to be statistically significant between these patients. But, differences were found regarding DEP, ANX, PAR, PSY, and GSI domains. The results suggest that the psychological status perhaps does not have close relationship with acid reflux. Remarkably, achalasia showed more psychological factors. Considering that achalasia is an unknown congenital disease, those factors will certainly exist because of refractory GERD symptoms. They probably are the result of symptoms from which patients have suffered for a quite long duration. Taken together, it appears that psychological factors will have a distinct effect on chronic diseases.5,16,17

With our other comparison results based on DeMeester value, we did not find difference between pathological and normal acid reflux. This strongly supports our suggestion that psychological status does not relate to acid reflux again. Possible reason is that the universal usage of PPIs has effectively controlled acid reflux; therefore, this makes patients benefit from reducing mental stress.

A large number of previous studies have revealed that patients with typical symptoms are apt to suffer from atypical GERD symptoms and FGID symptoms.18,19 Also, there is always an overlap between reflux symptoms, irritable bowel syndrome, and functional dyspepsia. The atypical GERD symptoms are closely related to the typical GERD symptoms.20 Unlike the study of Lee et al21 that showed that patients with symptomatic RE had more scores than patients with asymptomatic RE on all dimensions of SCL-90-R, we chose patients only with typical GERD symptom to compare with those with typical plus atypical GERD symptom. Our aim was to acquire more precise information about the relationship between mental disorder and GERD symptom.

The analysis of symptom duration in this study showed that the patients with more duration had more problems regarding DEP, ANX, and PSY. Considering gender difference, we investigated the data divided by females and males. Our results are consistent with those of Núñez-Rodríguez and Miranda Sivelo17 that women had dramatically higher scores than men in these nine domains by SCL-90-R. Due to more and more researchers paying attention to gender difference in chronic disease development,22-24 we assume that the difference between females and males is worthy of further investigations.

Regarding the measurement of mental disorders with SCL-90-R, some limitations are also prevailing in this study. The processes including interviewing, diagnosing, and rating were done by experts in our gastroenterology department. Although our research team acquired the assistance of psychologists, the results were likely to have a little bias. Moreover, the samples in this study were regional instead of a being nationally representative. Differences across cities and countries may occur due to differences in sociodemographics. Large-scale multicenter studies need to be carried out in future.

Footnotes

Source of support: Nil

Conflict of interest: None

REFERENCES

  • 1.Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013 Mar;108(3):308–328. doi: 10.1038/ajg.2012.444. [DOI] [PubMed] [Google Scholar]
  • 2.Fock KM, Talley N, Goh KL, Sugano K, Katelaris P, Holtmann G, Pandolfino JE, Sharma P, Ang TL, Hongo M et al. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett’s oesophagus. Gut. 2016 Sep;65(9):1402–1415. doi: 10.1136/gutjnl-2016-311715. [DOI] [PubMed] [Google Scholar]
  • 3.Fass R. Proton-pump inhibitor therapy in patients with gastroesophageal reflux disease: putative mechanisms of alure. Drugs. 2007;67:1521–1530. doi: 10.2165/00003495-200767110-00001. [DOI] [PubMed] [Google Scholar]
  • 4.You ZH, Perng CL, Hu LY, Lu T, Chen PM, Yang AC, Tsai SJ, Huang YS, Chen HJ. Risk of psychiatric disorders following gastroesophageal reflux disease: a nationwide population-based cohort study. Eur J Intern Med. 2015 Sep;26(7):534–539. doi: 10.1016/j.ejim.2015.05.005. [DOI] [PubMed] [Google Scholar]
  • 5.Cardin F, Ambrosio F, Amodio P, Minazzato L, Bombonato G, Schiff S, Finotti K, Giuliani D, Bianco T, Terranova C et al. Quality of life and depression in a cohort of female patients with chronic disease. BMC Surg. 2012 Nov;12(Suppl 1):S10. doi: 10.1186/1471-2482-12-S1-S10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bakir S, Kinis V, Bez Y, Gun R, Yorgancilar E, Ozbay M, Aguloglu B, Meric F. Mental health and quality of life in patients with chronic otitis media. Eur Arch Otorhinolaryngol. 2013 Feb;270(2):521–526. doi: 10.1007/s00405-012-2031-6. [DOI] [PubMed] [Google Scholar]
  • 7.Eitner S, Wichmann M, Schlegel A, Holst S. Clinical study on the correlation between psychogenic dental prosthesis incompatibility, oral stereognosis, and the psychologic diagnostic tools SCL-90-R and CES-D. Int J Prosthodont. 2007 Sep-Oct;20(5):538–545. [PubMed] [Google Scholar]
  • 8.Levy RL, Olden K, Naliboff BD, Bradley LA, Francisconi C, Drossman DA, Creed F. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology. 2006 May;130(5):1447–1458. doi: 10.1053/j.gastro.2005.11.057. [DOI] [PubMed] [Google Scholar]
  • 9.Paice JA, Ferrell B. The management of cancer pain. CA Cancer J Clin. 2011 May-Jun;61(3):157–182. doi: 10.3322/caac.20112. [DOI] [PubMed] [Google Scholar]
  • 10.Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale-preliminary report. Psychopharmacol Bull. 1973 Jan;9(1):13–28. [PubMed] [Google Scholar]
  • 11.Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry. 1976 Mar;128:280–290. doi: 10.1192/bjp.128.3.280. [DOI] [PubMed] [Google Scholar]
  • 12.Bredenoord AJ, Fox M, Kahrilas PJ, Pandolfino JE, Schwizer W, Smout AJ. International High Resolution Manometry Working Group. Chicago classification criteria esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012 Mar;24(Suppl 1):57–65. doi: 10.1111/j.1365-2982.2011.01834.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Mittal RK, Karstens A, Leslie E, Babaei A, Bhargava V .Ambulatory high-resolution manometry, lower esophageal sphincter lift and transient lower esophageal sphincter relaxation. Neurogastroenterol Motil. 2012 Jan;24(1):40–46. doi: 10.1111/j.1365-2982.2011.01816.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lim CH, Choi MG, Baeg MK, Moon SJ, Kim JS, Cho YK, Park JM, Lee IS, Kim SW, Choi KY. Symptom characteristics and psychosomatic profiles in different spectrum of gastroesophageal reflux disease. Gut Liver. 2014 Mar;8(2):165–169. doi: 10.5009/gnl.2014.8.2.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Jansson C, Nordenstedt H, Wallanger MA, Johansson S, Johnsen R, Hveem K, Lagergren J. Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Aliment Pharmacol Ther. 2007 Sep;26(5):683–691. doi: 10.1111/j.1365-2036.2007.03411.x. [DOI] [PubMed] [Google Scholar]
  • 16.Lee YC, Wang HP, Chiu HM, Liao SC, Huang SP, Lai YP, Wu MS, Chen MF, Lin JT. Comparative analysis between psychological and endoscopic profiles in patients with gastroesophageal reflux disease: a prospective study based on screening endoscopy. J Gastroenterol Hepatol. 2006 May;21(5):798–804. doi: 10.1111/j.1440-1746.2005.04034.x. [DOI] [PubMed] [Google Scholar]
  • 17.Núñez-Rodríguez MH, Miranda Sivelo A. Psychological factors in gastroesophageal reflux disease measured by scl-90-R questionnaire. Dig Dis Sci. 2008 Dec;53(12):3071–3075. doi: 10.1007/s10620-008-0276-0. [DOI] [PubMed] [Google Scholar]
  • 18.Nozu T, Komiyama H. Clinical characteristics of asymptomatic esophagitis. J Gastroenterol. 2008 Feb;43(1):27–31. doi: 10.1007/s00535-007-2120-2. [DOI] [PubMed] [Google Scholar]
  • 19.Neumann H, Monkemuller K, Kandulski A, Malfertheiner P. Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett’s esophagus. Dig Dis Sci. 2008 May;26(3):243–247. doi: 10.1159/000121354. [DOI] [PubMed] [Google Scholar]
  • 20.Rey E, Elola-Olaso CM, Rodriguez-Artalejo F, Locke GR 3rd, Diaz-Rubio M. Prevalence of atypical symptoms and their association with typical symptoms of gastroesophageal reflux in Spain. Eur J Gastroenterol Hepatol. 2006 Sep;18(9):969–975. doi: 10.1097/01.meg.0000230081.53298.03. [DOI] [PubMed] [Google Scholar]
  • 21.Lee SP, Lee KN, Lee OY, Lee HL, Choi HS, Yoon BC, Jun DW, Sohn W, Cho SC. The relationship between existence of typical symptoms and psychological factors in patients with erosive esophagitis. J Neurogastroenterol Motil. 2012 Jul;18(3):284–290. doi: 10.5056/jnm.2012.18.3.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Robles PG, Brooks D, Goldstein R, Salbach N, Mathur S. Gender-associated differences in pulmonary rehabilitation outcomes in people with chronic obstructive pulmonary disease: a systematic review. J Cardiopulm Rehabil Prev. 2014 Mar-Apr;34(2):87–97. doi: 10.1097/HCR.0000000000000018. [DOI] [PubMed] [Google Scholar]
  • 23.Baggio G, Corsini A, Floreani A, Giannini S, Zagonel V. Gender medicine: a task for the third millennium. Clin Chem Lab Med. 2013 Apr;51(4):713–727. doi: 10.1515/cclm-2012-0849. [DOI] [PubMed] [Google Scholar]
  • 24.Kotková P, Weiss P. Psychiatric factors related to sexual functioning in patients with Parkinson’s disease. Clin Neurol Neurosurg. 2013;115:419–424. doi: 10.1016/j.clineuro.2012.06.020. [DOI] [PubMed] [Google Scholar]

Articles from Euroasian Journal of Hepato-Gastroenterology are provided here courtesy of Jaypee Brothers Medical Publishing (P) Ltd.

RESOURCES